- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.2 2000 Non-officer Equity Incentive Plan
- 10.3 2000 Equity Incentive Plan
- 10.4 2008 Equity Incentive Plan
- 10.5 Amended and Restated Compensation Plan for Non-employee Directors
- 10.7 2011 Discretionary Incentive Compensation Policy
- 10.8 Amended and Restated Change of Control Severance Benefit Plan
- 21.1 Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Section 1350 Certifications
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-171747) of Nektar Therapeutics, and
(2) Registration Statements (Form S-8 Nos. 333-54078, 333-71936, 333-76638, 333-98321, 333-103040, 333-117975, 333-136498, 333-145259, 333-153106 and 333-170371) pertaining to the amended and restated 2000 Non-Officer Equity Incentive Plan, the 401(k) Retirement Plan, the Employee Stock Purchase Plan, the amended and restated 2000 Equity Incentive Plan, and the amended and restated 2008 Equity Incentive Plan of Nektar Therapeutics;
of our reports dated February 29, 2012, with respect to the consolidated financial statements and schedule of Nektar Therapeutics and the effectiveness of internal control over financial reporting of Nektar Therapeutics included in this Annual Report (Form 10-K) of Nektar Therapeutics for the year ended December 31, 2011.
/s/ ERNST & YOUNG LLP
Redwood City, California
February 29, 2012